Healthequity Inc (NASDAQ:HQY) – Stock analysts at Cantor Fitzgerald dropped their FY2018 earnings per share estimates for Healthequity in a research note issued on Wednesday. Cantor Fitzgerald analyst S. Halper now expects that the company will post earnings of $0.65 per share for the year, down from their prior estimate of $0.67. Cantor Fitzgerald currently has a “Buy” rating and a $56.00 target price on the stock.
Several other analysts also recently issued reports on the stock. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 target price on the stock in a research note on Wednesday, October 11th. BidaskClub downgraded shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Wednesday, October 18th. Oppenheimer reissued a “buy” rating and set a $61.00 target price on shares of Healthequity in a research note on Wednesday, September 6th. Robert W. Baird reissued a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Finally, Chardan Capital boosted their target price on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, December 6th. One analyst has rated the stock with a sell rating, two have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $58.33.
Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The company had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. During the same quarter in the prior year, the company earned $0.10 earnings per share. The firm’s revenue was up 31.0% on a year-over-year basis.
In related news, insider Stephen Neeleman sold 8,500 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $45.24, for a total value of $384,540.00. Following the completion of the sale, the insider now directly owns 1,000 shares in the company, valued at $45,240. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Ashley Dreier sold 10,000 shares of the company’s stock in a transaction on Monday, December 4th. The stock was sold at an average price of $50.97, for a total transaction of $509,700.00. Following the completion of the sale, the vice president now owns 15,652 shares of the company’s stock, valued at $797,782.44. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,743,212 shares of company stock worth $91,145,351. 19.00% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of the stock. Alps Advisors Inc. boosted its holdings in Healthequity by 0.3% in the second quarter. Alps Advisors Inc. now owns 10,729 shares of the company’s stock worth $535,000 after purchasing an additional 28 shares in the last quarter. Albion Financial Group UT boosted its holdings in Healthequity by 1.4% in the second quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock worth $433,000 after purchasing an additional 120 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Healthequity by 7.7% in the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after purchasing an additional 191 shares in the last quarter. Arizona State Retirement System boosted its holdings in Healthequity by 0.9% in the second quarter. Arizona State Retirement System now owns 23,097 shares of the company’s stock worth $1,151,000 after purchasing an additional 200 shares in the last quarter. Finally, Suntrust Banks Inc. boosted its holdings in Healthequity by 2.7% in the second quarter. Suntrust Banks Inc. now owns 9,408 shares of the company’s stock worth $468,000 after purchasing an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 98.60% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Healthequity Inc (HQY) to Post FY2018 Earnings of $0.65 Per Share, Cantor Fitzgerald Forecasts” was first reported by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.com-unik.info/2017/12/12/healthequity-inc-hqy-to-post-fy2018-earnings-of-0-65-per-share-cantor-fitzgerald-forecasts.html.
Healthequity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
What are top analysts saying about Healthequity? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Healthequity and related companies.